Expression of TTF‐1 and cytokeratins in primary and secondary epithelial lung tumours: correlation with histological type and grade
- 27 July 2004
- journal article
- Published by Wiley in Histopathology
- Vol. 45 (2) , 125-134
- https://doi.org/10.1111/j.1365-2559.2004.01893.x
Abstract
Aims: To assess cytokeratin (CK) and thyroid transcription factor (TTF)-1 expression in primary epithelial lung tumours by comparison with non-pulmonary carcinomas and to correlate it with their histological type and grade. Methods and results: Immunohistochemistry using antibodies against CKs 5/6, 7, 19, 20 and TTF-1 was applied to 165 primary and 37 secondary epithelial lung tumours. CK5/6 is a sensitive and specific marker of lung squamous carcinomas being positive in 100% of cases. CK7 is a common marker of primary lung adenocarcinomas (100% of cases) but with a lower specificity since it is also observed in other primary lung carcinomas (70% of large-cell neuroendocrine carcinomas, 40% of large-cell carcinomas, 23% of squamous carcinomas) but also in 27% of non-pulmonary adenocarcinomas. Addition of an anti-CK20 may be useful to prove or disprove the pulmonary origin of an adenocarcinoma when there is a history of colon cancer. CK19 is ubiquitous but a predominant or exclusive ‘dot-like’ pattern is very suggestive of high-grade neuroendocrine carcinoma. TTF-1 is a very sensitive and specific marker to document the pulmonary origin of an adenocarcinoma if a thyroid origin is excluded. Its expression in neuroendocrine lung tumours depends on the tumour grade. Conclusions: Immunohistochemical expression of CKs and TTF-1 may be correlated with histological type and grade of lung primary epithelial tumours and may allow them to be distinguished from non-pulmonary carcinomas.Keywords
This publication has 26 references indexed in Scilit:
- Expression of thyroid transcription factor‐1 in pulmonary and extrapulmonary small cell carcinomas and other neuroendocrine carcinomas of various primary sitesHistopathology, 2000
- Thyroid transcription factor‐1 is the superior immunohistochemical marker for pulmonary adenocarcinomas and large cell carcinomas compared to surfactant proteins A and BHistopathology, 2000
- Differential expression of thyroid transcription factor 1 in small cell lung carcinoma and merkel cell tumorHuman Pathology, 2000
- Utility of surfactant protein B precursor and thyroid transcription factor 1 in differentiating adenocarcinoma of the lung from malignant mesotheliomaHuman Pathology, 1999
- Histological Typing of Lung and Pleural TumoursPublished by Springer Nature ,1999
- Thyroid Transcription Factor-1 and Cytokeratins 7 and 20 in Pulmonary and Breast CarcinomaActa Cytologica, 1998
- TTF-1 gene expression in human lung tumoursEuropean Journal Of Cancer, 1996
- Monoclonal Antibody to Thyroid Transcription Factor-1: Production, Characterization, and Usefulness in Tumor DiagnosisHybridoma, 1996
- Cytoplasmic Domain of the Ubiquitous Na+/H+ Exchanger NHE1 Can Confer Ca2+ Responsiveness to the Apical Isoform NHE3Published by Elsevier ,1995
- The catalog of human cytokeratins: Patterns of expression in normal epithelia, tumors and cultured cellsPublished by Elsevier ,1982